CHANGES IN THE ACTIVITY OF ACID HYDROLASES DURING RENAL REABSORPTION OF LYSOZYME by Maack, Thomas
CHANGES  IN  THE  ACTIVITY  OF  ACID  HYDROLASES
DURING  RENAL  REABSORPTION  OF  LYSOZYME
THOMAS  MAACK.  From the  Department  of  Physiology,  the  State  University  of  New  York,  Upstate
Medical  Center,  Syracuse,  New York  13210
Biochemical  (1,  2) and morphological  (3-5) studies
indicate that proteins being reabsorbed from proxi-
mal tubules  of the kidney are concentrated  within
cells  in  lysosome-like  bodies.  However,  little  is
known about the quantitative relationship  between
the  activity  of individual  lysosomal  enzymes  and
the  uptake of proteins by tubular cells.  It  has been
shown  that,  18 hr after  the  administration  of egg
white,  the activity of some,  but not all,  hydrolytic
enzymes is increased in the rat kidney  (1).  In pres-
ent  experiments  the  time  course  of  lysozyme  re-
absorption  by  the  kidney  was  studied,  and  the
activities  of three  lysosomal  enzymes  were  meas-
ured at different  times following  administration  of
lysozyme;  actinomycin  D  was  administered  in  an
attempt  to inhibit the  increase  in enzyme  activity
induced by the protein. Lysozyme  has a low molec-
ular weight of 14,000,  can be  measured  with accu-
racy  and  reproducibility,  and in the doses  admin-
istered  it has no manifest  pathological effects  upon
the  organism  or  the  kidney.  Injected  egg-white
lysozyme  is reabsorbed  by the kidney and accumu-
lates  in  the  form  of "droplets"  in  the  proximal
tubular  cells  (6,  7).  It  has  been  shown  recently
(8)  that  lysozyme,  in  the  normal  rat  kidney,  is
associated  with the  lysosomal fraction.  The  above
properties  make  lysozyme  a  suitable  molecule  to
be  used  as  a tracer protein  in  the  studies of renal
uptake  and metabolism  of injected  proteins.
METHODS
Male  mice,  25-30  g  in weight,  were  used  as  experi-
mental  animals.  Lysozyme  2X  crystallized
(Worthington  Corporation,  Harrison,  N.J.),  or
lysozyme  chloride  3X  crystallized  (Sigma  Chemical
Co.,  St.  Louis,  Mo.),  was  dissolved  in  0.9%  NaCI
and  injected  intraperitoneally.  Control  animals
received  an equivalent  volume of 0.9%  NaCI  (1 ml).
At several  time  intervals following  the administration
of lysozyme,  the animals  were  sacrificed by  a blow on
the  head,  the  kidneys  were  removed,  and  fine  slices
of cortical tissue were cut out with a razor blade.  The
slices  were  washed  in ice-cold  saline,  blotted  with  a
filter  paper,  and  weighed  on  a  torsion  balance.
Homogenates  were  made  in distilled water  and were
frozen  and  thawed  three  times  to  ensure  release  of
the enzymes.  Lysosomal  enzymes  and  lysozyme were
determined  in  each  homogenate.  Acid  ribonuclease
(acid  RNase)  activity  (9)  was  assayed  at  pH  5.0
(acetate buffer)  with purified  RNA  (10)  as substrate.
Cathepsin  was  measured  (11)  with denatured  hemo-
globin  as  substrate.  Acid  phosphatase  was  assayed
either  with  disodium  phenylphosphate  (12)  or  -
glycerophosphate  (13)  as  substrate.  All  enzyme
assays  were  tested  for  linearity.  Protein  was  deter-
mined  by the method  of Lowry  et  al.  (14).  Lysozyme
was  assayed  by  a  modification  of  the  turbimetric
procedure  of Shugar  (15).  Homogenates  were centri-
fuged at 2,000  rpm  for  30 min  at 4°C; 0.1  ml of a
conveniently  diluted  supernatant  was  added,  with
immediate  mixing, to  1 ml of a freshly  prepared  bac-
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FIGURE 1  Specific  activities of lysozyme,  acid RNase,  cathepsin,  and acid  phosphatase in  mouse kidney
cortex homogenates at several time intervals following an intraperitoneal  injection  of 1 mg/g body weight
mouse  of  3X  crystallized  lysozyme  chloride.  At each  time interval  a group  of five  animals  was used  to
assay  the activities  of lysozyme,  acid RNase,  and cathepsin.  Dots and bars represent  mean  q- standard
deviation.  Values  indicated  at time  0 are  those  from  the five  animals  receiving 0.9%  NaCI  and sacri-
ficed at  9 hr. Significance  of  the difference  between  the means  of  treated and control animals  (time  0)
was  tested by the t test and are indicated in the figure by: * significant  (0.01  <  P  <  0.05);  **  highly sig-
nificant  (P <  0.01).  Acid  phosphatase  values  (  glycerophosphate  as substrate)  were  obtained  from  a
separate  set  of  animals  and  activities  at  each  time  interval  represent  those  of  kidney  cortices  pooled
from  four mice.  The  solid  lines connecting  the points are  drawn  for illustrative  purposes  only.
terial  solution  containing  30  mg/100  ml  of  lyophi-
lized  Micrococcus lisodeikticus cell  walls  (Worthington
Corporation)  and  100 mg/100  ml  NaCI  in phosphate
buffer  0.06  M (pH  6.60).  The  increase  in transmit-
tance  was determined at 475  mu at a temperature  of
24  :
1 1 C and was registered  by means of a recorder
attached  to the spectrophotometer.  The linear  region
of the curve was related  to that of lysozyme  standards
and  the  activity  was  expressed  as  equivalent  micro-
grams  lysozyme  per  milligrams  protein.  Under  the
conditions  used,  increase  in  transmittance  is  linear
between  Hi  and  3  min  or  more  when  1-10  Ajg  of
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ITABLE  I
Concentration of Injected Lysozyme  in Blood Serum
Hours  0  3  6  9  12  24  36
Lysozyme  1.5  302.0  96.5  22.8  3.0  2.3  1.2
Serum lysozyme  (g/ml)  at  several  time intervals  after  the intraperitoneal  adminis-
tration  of 1 mg/g body weight of lysozyme.  Each value was obtained by pooling  serum
of two  mice.
lysozyme  is  added.  The  reproducibility  was  better
than  5%,  and  the  average  recovery,  by  adding
lysozyme  to  the  samples,  was  96/0%.  When  used,
actinomycin D  (Merck,  Sharp &  Dohme, West  Point,
Pa.)  was  injected  intraperitoneally  in buffered  saline
(0.9%  NaCI  in  buffer  phosphate  0.04  M, pH  7.4).
Dosages  and schedules  are given in the results. Blood
was  collected  by  cardiac  puncture  and  serum  ac-
tivities  of  lysozyme,  and  the  acid  hydrolases  were
measured  in both control  and  experimental  animals.
RESULTS
Data from  a  typical  experiment  showing  the  time
course of lysozyme  reabsorption and disappearance
from  renal  cortex  and  the  corresponding  specific
activities of acid  RNase,  cathepsin,  and  acid  phos-
phatase  are  given  in Fig.  1.  The  peak of lysozyme
activity  is  reached  around  9  hr  after  the  admin-
istration of the protein.  From 9 to  18 hr (and 24  hr
in  experiments not shown  in Fig.  1) values of lyso-
zyme remained  at a fairly constant level. At about
54 hr activity reached  control levels. Table  I gives
the serum lysozyme  values of similarly treated ani-
mals.  As  can  be  seen,  the  maximum  activity  of
lysozyme  in  renal  cortex  is  attained  at the  time  of
its very sharp exponential  fall in blood.
Acid-phosphatase  activity  remained  unchanged
during  the  cycle  of  lysozynre  in  renal  cortex,  but
specific  activities  of acid  RNase  and cathepsin  are
significantly  increased  following  lysozyme  admin-
istration.  However,  cathepsin activity increased  at
a  slower  rate  and reached  a peak  of activity later
than acid  RNase.  In three  other experiments,  not
shown  in Fig.  1, the  specific  activity  of acid  phos-
phatase,  with  phenylphosphate  as  substrate,  did
not  change.  Further  experiments  have  confirmed
the earlier rise  in acid RNase activity compared  to
cathepsin;  increase  in  acid  RNase  activity  was
observed  as early  as  3 hr after  lysozyme  adminis-
tration.  The  time  course  of return  of  acid  RNase
activity  to  the  control  levels  is  variable;  in  some
experiments the enzyme returned  to control  levels
as  early  as  18  hr  after  lysozyme  administration,
TABLE  II
Dose-accumulation Relationship of  Lysozyme  and Activities
of Acid RNase in Renal Cortex
Lysozyme  Lysozyme  in
administered  Acid  RNase A  OD  renal  cortex
mg/g  body  wt  102/mg  protein/30  min  jug/mg  protein
0*  26.2  2.34  0.7§
0.05  26.9  4.8  10.4
0.20  31.0  3.61  18.2
0.50  33.7  4.411  22.5
1.00  45.0  4.01T  25.7
Specific  activities  of acid  RNase  and  lysozyme  in
mouse  renal  cortex  9  hr  after  the intraperitoneal
administration  of  increasing  doses  of  lysozyme.
*Each  group  consists  of  four  animals.
mean  4  standard  deviation.
§ average value.
Difference  between  means  of treated  and  control
animals tested  by the  t test:
110.01  <  p  <  0.05.
¶p  <  0.01.
and  in  others,  at  this  time,  the  enzyme  activity
was similar  to  that  observed  at  the time  point  of
9 hr. The experiment  illustrated in Fig.  , however,
represents  the most frequent finding.
Average  values of cathepsin  and  acid  RNase  in
serum were found to be very low (0.12  ug tryosyne/
microliter serum/30 min  and  6  X  10
-
3  A  optical
density/microliter  serum/30 min)  and did  not  in-
crease  after lysozyme  administration.
Table II  shows  the relationship  between  dose of
lysozyme  administered,  accumulation  of lysozyme
in  renal  cortex,  and  the  specific  activity  of  acid
RNase.  In  the  range  studied,  the  dose accumu-
lation relationship  of lysozyme  is not linear, and the
increase  in  acid  RNase  activity could  be detected
only  when  the  lysozyme  present  in  renal  cortex
was about 25 times greater than in control animals.
Actinomycin  D, an  inhibitor of RNA synthesis,
was used  in an  attempt  to influence  the  increased
activity of the  enzymes  induced  by  lysozyme. The
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Action of Actinomycin  D  upon Lysozyme-Induced Increase in
Acid RNase and Cathepsin Activities
Treatment  Acid  RNase  Lysozyme
(mean  :  SD)
Saline  26.1  ±  2.3  <1.0
Saline  +  AM  24.2  :  2.4  <1.0
Lysozyme  43.3  - 5.9  17.7
Lysozyme  +  AM  I  44.1  - 4.8  18.2
Lysozyme  +  AM  II  33.3  - 8.8  21.0
Lysozyme  +  AM  IIIt  26.7  24.1
Treatment}  Cathepsin  Lysozyme
Saline  12.8  1.7  <1.0
Saline  +  AM  15.3  - 1.6  <1.0
Lysozyme  23.2  - 1.7  21.6
Lysozyme  +  AM  IV  28.7  - 5.2  13.4
Lysozyme  +  AM  VIi  25.0  4-  5.6  6.7
Action  of actinomnycin  D  (AM)  upon  specific  ac-
tivities  of mouse  kidney,  cortex  acid  RNase,  and
cathepsin in lysozyme-treated  and control  animals.
Average  concentration  of lysozyme  in  kidney  cor-
tex  for each  group  is  also shown.  Except  as  noted,
each  group  consisted  of five  animals.
* Animals sacrificed  9 hr  following intraperitoneal
administration  of 30  mg 2X  crystallized  lysozyme
or  saline  (I  ml).
I  Two  animals  alive  from a  group  of 5;
§ Animals sacrificed  18 hr following administration
of  lysozyme  or  saline;
JI  Three  animals  alive  from  a  group of seven.
Units  of  acid  RNase,  cathepsin  and  lysozyme  as
given  in Fig.  1.
Doses  and  schedules  of  AM  administration  were
as  follows:
AM  I,  two  doses  of  5  g  each,  given  24  and  2
hr  before lysozyme  administration;
AM  II,  two  doses of  10  /pg each,  given  as AM  I;
AM III,  two doses of  15  g  each,  given  as AM I;
AM  IV,  four  doses of 3  Atg  each,  given at 24,  12,
0  hr  before  and  9  hr  after  lysozyme  adminis-
tration;
AM V,  four  doses of 5  /pg each,  given  as  in AM
IV.
results  are summarized  in Table III. Actinomycin
D at high doses inhibited  a great proportion  of the
increase  in  acid  RNase  activity,  but  it  was  not
possible to inhibit the increase in  cathepsin activity
even  with doses  that killed  more  than 50 % of the
animals  in the  group.  Schedules  of actinomycin  D
administration  different  from  those  presented  in
Table  III were also tried with similar results:  12.5
/gg of actinomycin  D  given  2  hr before  lysozyme
administration  inhibited  72.5%  of the  increase  in
acid RNase activity but did not change the increase
in cathepsin activity.  The influence  of actinomycin
D  upon the  increase  in  acid  RNase  activity is  not
due to its interference  with the  renal uptake  of the
protein, as the  accumulation of lysozyme  in kidney
cortex shows the same pattern whether the animals
were  treated  or  untreated  with  actinomycin  D
(Table III,  top).  18  hr after  the  protein  adminis-
tration,  lysozyme  activity is significantly less in the
animals that also received  actinomycin D, and this
antibiotic  slightly enhances  the increase in cathep-
sin  activity  that  is  seen  in  the  animals  receiving
only  lysozyme  (Table  III,  bottom).
DISCUSSION
Data  presented  demonstrate  the  independent  be-
havior  of the  individual  acid hydrolases  studied  in
face  of  the  stimuli of  lysozyme  uptake by  the  kid-
ney.  The  increase  in  activity  of  acid  RNase  and
cathepsin  not only differs in rate but probably also
in  nature.  The  complexity  of  the  system  used
precludes a definitive elucidation of the mechanism
by  which  the  enzyme  activities  are increased,  but
results  of  the  actinomycin  D  experiments  suggest
that  the increase  in acid  RNase  activity is  due, at
least  partially,  to  a de  novo synthesis  of the enzyme
while  that  of cathepsin  is  not.  It  is  possible  that
lysozyme  enhances  cathepsin  activity  by  reducing
its  rate  of degradation  rather  than  by  increasing
its rate  of synthesis;  the  stabilization of an enzyme
by its substrate has already been reported  for other
enzyme-substrate  systems  in  vivo  (see  reference
16).
It  has been demonstrated  (1)  that egg white ad-
ministration  increased  the  activity  of  acid  RNase
and cathepsin  in the rat kidney  cortex,  while  acid
phosphatase  remained  unchanged.  Present  results
confirm  and  extend  this  observation.  In  view  of
quantitative  considerations,  it  is unlikely  that  the
results  obtained  with  egg  white  are  due  to  its
lysozyme  content.  Furthermore,  methyl  lysozynme
and  trypan blue  also increase  acid  RNase  activity
in  mouse  kidney  cortex  (unpublished  data).  The
role  of kidney  acid  hydrolases  in the  fate  of reab-
sorbed  proteins  is still  unclear  but it  is likely  that
cathepsin  has  an  important  function  in  the  han-
dling  of the  reabsorbed  protein.  The  relationship
between  increased  cathepsin  activity  and  the  dis-
appearance  of injected lysozyme from renal cortex,
the  possibility  that  lysozyme  stabilizes  cathepsin
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fact  that  mouse  kidney  cortex  homogenates  hy-
drolyse  lysozyme  in vitro  (unpublished  data)  add
evidence  to the assumption that cathepsin is catab-
olizing  the reabsorbed  protein.  The significance  of
the early  rise  in acid  RNase  needs further investi-
gation  to  be  established.  It  appears  that  the
increase  in  acid RNase  is  not essential  for the  dis-
posal  of the  reabsorbed  protein because,  once  it is
inhibited  by actinomycin  D,  lysozyme  disappears
from the  renal cortex at a faster than normal  rate
(Table III).
Although  only  total  activities  of  enzymes  were
measured  in  the present experiments,  preliminary
data  not  here  reported  show  that  the  three  acid
hydrolases  considered  have  a  distribution  pattern
and  latency  properties  characteristic  of lysosomal
enzymes.  The  finding  that  acid  phosphatase  re-
mains  unchanged  when  acid  RNase  increases  by
de  novo  synthesis  poses  some  questions  regarding
the  relationship  between  acid  hydrolases  and lyso-
somes.  Three  main  possibilities  are  considered:
(a) acid RNase, being synthesized at the ribosomes,
migrates to  preformed  lysosomes, and  changes the
previous  balance  of enzyme  concentration  in  the
particle;  (b) lysosomes are heterogeneous  in respect
to their  enzyme  content,  and  the  increase  in  acid
RNase  activity  could  be  an  expression  of  a  more
rapid  turnover  of lysosomes  rich  in  this  enzyme
and  poor in  acid  phosphatase content;  and  (c) in-
creased  synthesis of acid RNase not bound  to lyso-
somes  occurs. With  respect to the last possibility  it
should  be  noted  that  several  azo-dyes  (17)  and
some  proteins  (6),  including  lysozyme,  greatly  in-
crease  the  activity  of alkaline  RNase,  an  enzyme
not considered  to be related  to lysosomes.  A study,
now  in  process,  pertaining  to  the  intracellular
distribution  of  lysozyme  and  acid  hydrolases  at
several  time  intervals  after  lysozyme  administra-
tion should  permit further elucidation  of the  rela-
tionship between  the process  of renal reabsorption
of  proteins  and  the  role  of  lysosomes  and  acid
hydrolases.
SUMMARY
Present  studies  quantitatively  describe  the  cycle
of injected  lysozyme and  the concomitant  changes
in the  specific activity  of acid  hydrolases  in  mouse
kidney  cortex.  The  increase  in  acid  ribonuclease
activity corresponds  to the phase  of lysozyme accu-
mulation  and  that  of  cathepsin  activity  to  the
leveling off and  disappearance of the  protein from
renal  cortex.  It  was  demonstrated  that  actino-
mycin D inhibits the  increase  in  acid ribonuclease
but has no effect on  the increase  in cathepsin.  The
results  suggest  that the  increase  in acid  ribonucle-
ase is  due  to a  de novo  synthesis of the enzyme and
it is  possible  that the changes  in  cathepsin activity
are  a result  of  the  stabilization  of the enzyme  by
its substrate.
The  relationship  b-tween  renal  uptake  of pro-
teins and the role of acid hydrolases and lysosomes
is briefly discussed.
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